{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:32:45Z","timestamp":1791988365980,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T00:00:00Z","timestamp":1725753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T00:00:00Z","timestamp":1725753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["200481"],"award-info":[{"award-number":["200481"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Despite national guidelines and use of intrapartum antibiotic prophylaxis (IAP), <jats:italic>Streptococcus agalactiae<\/jats:italic> (group B streptococci (GBS)) is still a leading cause of morbidity and mortality in newborns in Europe and the United States. The European DEVANI (Design of a Vaccine Against Neonatal Infections) program assessed the neonatal GBS infection burden in Europe, the clinical characteristics of colonized women and microbiological data of GBS strains in colonized women and their infants with early-onset disease (EOD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Overall, 1083 pregnant women with a GBS-positive culture result from eight European countries were included in the study. Clinical obstetrical information was collected by a standardized questionnaire. GBS strains were characterized by serological and molecular methods.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among GBS carriers included in this study after testing positive for GBS by vaginal or recto-vaginal sampling, 13.4% had at least one additional obstetrical risk factor for EOD. The five most common capsular types (i.e., Ia, Ib, II, III and V) comprised\u2009~\u200993% of GBS carried. Of the colonized women, 77.8% received any IAP, and in 49.5% the IAP was considered appropriate. In our cohort, nine neonates presented with GBS early-onset disease (EOD) with significant regional heterogeneity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Screening methods and IAP rates need to be harmonized across Europe in order to reduce the rates of EOD. The epidemiological data from eight different European countries provides important information for the development of a successful GBS vaccine.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s15010-024-02380-0","type":"journal-article","created":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T10:02:07Z","timestamp":1725789727000},"page":"373-381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Maternal Streptococcus agalactiae colonization in Europe: data from the multi-center DEVANI study"],"prefix":"10.1007","volume":"53","author":[{"given":"Florens","family":"Lohrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Androulla","family":"Efstratiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uffe B. Skov","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Creti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoaneta","family":"Decheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"K\u0159\u00ed\u017eov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Koz\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Rodriguez-Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"De La Rosa Fraile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculada","family":"Margarit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rinaudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Telford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Orefici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mogens","family":"Kilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baharak","family":"Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierrette","family":"Melin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Berner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hufnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Kunze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DEVANI Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Karstens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Baldassarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Rigat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Imperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,8]]},"reference":[{"key":"2380_CR1","doi-asserted-by":"publisher","first-page":"D31","DOI":"10.1016\/j.vaccine.2013.05.012","volume":"31","author":"P Melin","year":"2013","unstructured":"Melin P, Efstratiou A. Group B streptococcal epidemiology and vaccine needs in developed countries. Vaccine. 2013;31:D31-42. https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.012.","journal-title":"Vaccine"},{"key":"2380_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1056\/NEJM200001063420103","volume":"342","author":"SJ Schrag","year":"2000","unstructured":"Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15\u201320. https:\/\/doi.org\/10.1056\/NEJM200001063420103.","journal-title":"N Engl J Med"},{"key":"2380_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(11)61651-6","volume":"379","author":"KM Edmond","year":"2012","unstructured":"Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AKM, Cousens S, Heath PT. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012;379:547\u201356. https:\/\/doi.org\/10.1016\/S0140-6736(11)61651-6.","journal-title":"Lancet"},{"key":"2380_CR4","doi-asserted-by":"publisher","first-page":"e20191881","DOI":"10.1542\/peds.2019-1881","volume":"144","author":"KM Puopolo","year":"2019","unstructured":"Puopolo KM, Lynfield R, Cummings JJ, Hand I, Adams-Chapman I, Poindexter B, Stewart DL, Aucott SW, Goldsmith JP, Mowitz M, Watterberg K, Maldonado YA, Zaoutis TE, Banerjee R, Barnett ED, Campbell JD, Gerber JS, Kourtis AP, Munoz FM, Nolt D, Nyquist AC, O\u2019Leary ST, Sawyer MH, Steinbach WJ, Zangwill K, Committee on fetus and newborn, Committee on infectious diseases. Management of infants at risk for group B Streptococcal disease. Pediatrics. 2019;144:e20191881. https:\/\/doi.org\/10.1542\/peds.2019-1881.","journal-title":"Pediatrics"},{"key":"2380_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s15010-022-01965-x","volume":"51","author":"F Lohrmann","year":"2023","unstructured":"Lohrmann F, Hufnagel M, Kunze M, Afshar B, Creti R, Detcheva A, Kozakova J, Rodriguez-Granger J, S\u00f8rensen UBS, Margarit I, Maione D, Rinaudo D, Orefici G, Telford J, de la Rosa FM, Kilian M, Efstratiou A, Berner R, Melin P. Neonatal invasive disease caused by Streptococcus agalactiae in Europe: the DEVANI multi-center study. Infection. 2023;51:981\u201391. https:\/\/doi.org\/10.1007\/s15010-022-01965-x.","journal-title":"Infection"},{"key":"2380_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.11.056","author":"SJ Schrag","year":"2013","unstructured":"Schrag SJ, Verani J. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2013. https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.056.","journal-title":"Vaccine"},{"key":"2380_CR7","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/AOG.0b013e318219229b","volume":"117","author":"ACOG (American Congress of Obstetricians and Gynecologists) Committee on Obstetric Practice","year":"2011","unstructured":"ACOG (American Congress of Obstetricians and Gynecologists) Committee on Obstetric Practice. ACOG committee opinion no 485: prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol. 2011;117:1019\u201327. https:\/\/doi.org\/10.1097\/AOG.0b013e318219229b. PMID: 31977793.","journal-title":"Obstet Gynecol"},{"key":"2380_CR8","unstructured":"Verani M JR, L S, S.J. (2010) Division of bacterial diseases, national center for immunization and respiratory diseases, centers for disease control and prevention (CDC. Prevention of perinatal group B streptococcal disease\u2013revised guidelines from CDC 59:1\u201336"},{"key":"2380_CR9","first-page":"1","volume":"51","author":"S Schrag","year":"2002","unstructured":"Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revis Guidel CDC Morb Mort Wkly Rep Recomm Rep. 2002;51:1\u201322.","journal-title":"Revis Guidel CDC Morb Mort Wkly Rep Recomm Rep"},{"key":"2380_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.14821","author":"RG Hughes","year":"2017","unstructured":"Hughes RG, Brocklehurst P, Steer PJ, Heath P. Stenson BM on behalf of the royal college of obstetricians and gynaecologists prevention of early-onset neonatal group B streptococcal disease. Green-top Guidel. 2017. https:\/\/doi.org\/10.1111\/1471-0528.14821.","journal-title":"Green-top Guidel"},{"key":"2380_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1515\/jpm.2011.037","volume":"39","author":"M Kunze","year":"2011","unstructured":"Kunze M, Ziegler A, Fluegge K, Hentschel R, Proempeler H, Berner R. Colonization, serotypes and transmission rates of group B streptococci in pregnant women and their infants born at a single university center in Germany. J Perinat Med. 2011;39:417\u201322. https:\/\/doi.org\/10.1515\/jpm.2011.037.","journal-title":"J Perinat Med"},{"key":"2380_CR12","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s10096-012-1559-0","volume":"31","author":"J Rodriguez-Granger","year":"2012","unstructured":"Rodriguez-Granger J, Alvargonzalez JC, Berardi A, Berner R, Kunze M, Hufnagel M, Melin P, Decheva A, Orefici G, Poyart C, Telford J, Efstratiou A, Killian M, Krizova P, Baldassarri L, Spellerberg B, Puertas A, Rosa-Fraile M. Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project. Eur J Clin Microbiol Infect Dis. 2012;31:2097\u2013104. https:\/\/doi.org\/10.1007\/s10096-012-1559-0.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2380_CR13","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1473-3099(14)70919-3","volume":"14","author":"V Bekker","year":"2014","unstructured":"Bekker V, Bijlsma MW, van de Beek D, Kuijpers TW, van der Ende A. Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study. Lancet Infect Dis. 2014;14:1083\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(14)70919-3.","journal-title":"Lancet Infect Dis"},{"key":"2380_CR14","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.1093\/cid\/cix655","volume":"65","author":"NJ Russell","year":"2017","unstructured":"Russell NJ, Seale AC, O\u2019Sullivan C, Le Doare K, Heath PT, Lawn JE, Bartlett L, Cutland C, Gravett M, Ip M, Madhi SA, Rubens CE, Saha SK, Schrag S, Sobanjo-Ter Meulen A, Vekemans J, Baker CJ. Risk of early-onset neonatal group b streptococcal disease with maternal colonization worldwide systematic review meta-analyses. Clin Infect Dis. 2017;65:S152\u20139. https:\/\/doi.org\/10.1093\/cid\/cix655.","journal-title":"Clin Infect Dis"},{"key":"2380_CR15","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s10096-012-1559-0","volume":"31","author":"J Rodriguez-Granger","year":"2012","unstructured":"Rodriguez-Granger J, Alvargonzalez JC, Berardi A, Berner R, Kunze M, Hufnagel M, Melin P, Decheva A, Orefici G, Poyart C, Telford J, Efstratiou A, Killian M, Krizova P, Baldassarri L, Spellerberg B, Puertas A, Rosa-Fraile M. Prevention of group B streptococcal neonatal disease revisited DEVANI European project. Eur J Clin Microbiol Infect Dis. 2012;31:2097\u2013104. https:\/\/doi.org\/10.1007\/s10096-012-1559-0.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2380_CR16","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/cid\/ciw377","volume":"63","author":"M Fabbrini","year":"2016","unstructured":"Fabbrini M, Rigat F, Rinaudo CD, Passalaqua I, Khacheh S, Creti R, Baldassarri L, Carboni F, Anderloni G, Rosini R, Maione D, Grandi G, Telford JL, Margarit I. The protective value of maternal group B Streptococcus antibodies: quantitative and functional analysis of naturally acquired responses to capsular polysaccharides and pilus proteins in European maternal sera. Clin Infect Dis. 2016;63:746\u201353. https:\/\/doi.org\/10.1093\/cid\/ciw377.","journal-title":"Clin Infect Dis"},{"key":"2380_CR17","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1128\/JCM.02365-10","volume":"49","author":"B Afshar","year":"2011","unstructured":"Afshar B, Broughton K, Creti R, Decheva A, Hufnagel M, Kriz P, Lambertsen L, Lovgren M, Melin P, Orefici G, Poyart C, Radtke A, Rodriguez-Granger J, S\u00f8rensen UBS, Telford J, Valinsky L, Zachariadou L, Efstratiou A, Members of the DEVANI Study Group. International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (group B streptococci). J Clin Microbiol. 2011;49:1475\u201382.","journal-title":"J Clin Microbiol"},{"key":"2380_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1128\/JCM.02417-12","volume":"51","author":"K Yao","year":"2013","unstructured":"Yao K, Poulsen K, Maione D, Rinaudo CD, Baldassarri L, Telford JL, S\u00f8rensen UBS, Kilian M, Members of the DEVANI Study Group. Capsular gene typing of Streptococcus agalactiae compared to serotyping by latex agglutination. J Clin Microbiol. 2013;51:503\u20137. https:\/\/doi.org\/10.1128\/JCM.02417-12.","journal-title":"J Clin Microbiol"},{"key":"2380_CR19","doi-asserted-by":"publisher","first-page":"e0125985","DOI":"10.1371\/journal.pone.0125985","volume":"10","author":"R Rosini","year":"2015","unstructured":"Rosini R, Campisi E, De Chiara M, Tettelin H, Rinaudo D, Toniolo C, Metruccio M, Guidotti S, S\u00f8rensen UBS, Kilian M, Ramirez M, Janulczyk R, Donati C, Grandi G, Margarit I, DEVANI Consortium. Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus population. PLoS ONE. 2015;10:e0125985. https:\/\/doi.org\/10.1371\/journal.pone.0125985.","journal-title":"PLoS ONE"},{"key":"2380_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/INF.0000000000002943","volume":"40","author":"F Lohrmann","year":"2021","unstructured":"Lohrmann F, Berg A, Wicker E, Imm A, Krause G, Z\u00fcrn K, Berner R, Hufnagel M, Lander F. Prevalence of capsular serotype, Pilus Island distribution, and antibiotic resistance in pediatric and adult invasive Group B Streptococcus isolates: data from a nationwide prospective surveillance study in Germany. Pediatr Infect Dis J. 2021;40:76\u201382. https:\/\/doi.org\/10.1097\/INF.0000000000002943.","journal-title":"Pediatr Infect Dis J"},{"key":"2380_CR21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/INF.0000000000001414","volume":"36","author":"R Creti","year":"2017","unstructured":"Creti R, Imperi M, Berardi A, Pataracchia M, Recchia S, Alfarone G, Baldassarri L, Italian Neonatal GBS Infections Working Group. Neonatal group B streptococcus infections: prevention strategies, clinical and microbiologic characteristics in 7 years of surveillance. Pediatr Infect Dis J. 2017;36:256\u201362. https:\/\/doi.org\/10.1097\/INF.0000000000001414.","journal-title":"Pediatr Infect Dis J"},{"key":"2380_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1473-3099(20)30478-3","volume":"21","author":"J Absalon","year":"2021","unstructured":"Absalon J, Segall N, Block SL, Center KJ, Scully IL, Giardina PC, Peterson J, Watson WJ, Gruber WC, Jansen KU, Peng Y, Munson S, Pavliakova D, Scott DA, Anderson AS. Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1\/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial. Lancet Infect Dis. 2021;21:263\u201374. https:\/\/doi.org\/10.1016\/S1473-3099(20)30478-3.","journal-title":"Lancet Infect Dis"},{"key":"2380_CR23","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1016\/s0264-410x(03)00353-0","volume":"21","author":"CJ Baker","year":"2003","unstructured":"Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine. 2003;21:3468\u201372. https:\/\/doi.org\/10.1016\/s0264-410x(03)00353-0.","journal-title":"Vaccine"},{"key":"2380_CR24","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.1016\/j.vaccine.2020.08.056","volume":"38","author":"GK Swamy","year":"2020","unstructured":"Swamy GK, Metz TD, Edwards KM, Soper DE, Beigi RH, Campbell JD, Grassano L, Buffi G, Dreisbach A, Margarit I, Karsten A, Henry O, Lattanzi M, Bebia Z. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: results from a randomized placebo-controlled phase II trial. Vaccine. 2020;38:6930\u201340. https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.056.","journal-title":"Vaccine"},{"key":"2380_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa2116045","volume":"389","author":"SA Madhi","year":"2023","unstructured":"Madhi SA, Anderson AS, Absalon J, Radley D, Simon R, Jongihlati B, Strehlau R, van Niekerk AM, Izu A, Naidoo N, Kwatra G, Ramsamy Y, Said M, Jones S, Jose L, Fairlie L, Barnabas SL, Newton R, Munson S, Jefferies Z, Pavliakova D, Silmon de Monerri NC, Gomme E, Perez JL, Scott DA, Gruber WC, Jansen KU. Potential for maternally administered vaccine for infant group B streptococcus. N Engl J Med. 2023;389:215\u201327. https:\/\/doi.org\/10.1056\/NEJMoa2116045.","journal-title":"N Engl J Med"},{"key":"2380_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.mimet.2009.11.010","volume":"80","author":"M Imperi","year":"2010","unstructured":"Imperi M, Pataracchia M, Alfarone G, Baldassarri L, Orefici G, Creti R. A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. J Microbiol Methods. 2010;80:212\u20134. https:\/\/doi.org\/10.1016\/j.mimet.2009.11.010.","journal-title":"J Microbiol Methods"},{"key":"2380_CR27","doi-asserted-by":"publisher","unstructured":"Prevention of group B streptococcal early-onset disease in newborns: ACOG committee opinion summary, Number 797. Obstet Gynecol. 2020;135(2):489\u2013492. https:\/\/doi.org\/10.1097\/AOG.0000000000003669.","DOI":"10.1097\/AOG.0000000000003669"},{"key":"2380_CR28","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.1093\/cid\/cix656","volume":"65","author":"L Madrid","year":"2017","unstructured":"Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT, Madhi SA, Baker CJ, Bartlett L, Cutland C, Gravett MG, Ip M, Le Doare K, Rubens CE, Saha SK, Sobanjo-Ter Meulen A, Vekemans J, Schrag S, Infant GBS Disease Investigator Group. Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65:S172. https:\/\/doi.org\/10.1093\/cid\/cix656.","journal-title":"Clin Infect Dis"},{"key":"2380_CR29","unstructured":"R Core Team (2024) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria"},{"key":"2380_CR30","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s12884-019-2681-0","volume":"19","author":"LL Vieira","year":"2019","unstructured":"Vieira LL, Perez AV, Machado MM, Kayser ML, Vettori DV, Alegretti AP, Ferreira CF, Vettorazzi J, Val\u00e9rio EG. Group B Streptococcus detection in pregnant women: comparison of qPCR assay, culture, and the Xpert GBS rapid test. BMC Pregnancy Childbirth. 2019;19:532. https:\/\/doi.org\/10.1186\/s12884-019-2681-0.","journal-title":"BMC Pregnancy Childbirth"},{"key":"2380_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1128\/JCM.42.1.83-89.2004","volume":"42","author":"SM Hansen","year":"2004","unstructured":"Hansen SM, Uldbjerg N, Kilian M, S\u00f8rensen UBS. Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. J Clin Microbiol. 2004;42:83\u20139. https:\/\/doi.org\/10.1128\/JCM.42.1.83-89.2004.","journal-title":"J Clin Microbiol"},{"key":"2380_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00431-015-2548-y","volume":"174","author":"M Kunze","year":"2015","unstructured":"Kunze M, Zumstein K, Markfeld-Erol F, Elling R, Lander F, Pr\u00f6mpeler H, Berner R, Hufnagel M. Comparison of pre- and intrapartum screening of group B streptococci and adherence to screening guidelines: a cohort study. Eur J Pediatr. 2015;174:827\u201335. https:\/\/doi.org\/10.1007\/s00431-015-2548-y.","journal-title":"Eur J Pediatr"},{"key":"2380_CR33","doi-asserted-by":"publisher","first-page":"e0281707","DOI":"10.1371\/journal.pone.0281707","volume":"18","author":"KH Kjerulff","year":"2023","unstructured":"Kjerulff KH, Attanasio LB, Vanderlaan J, Sznajder KK. Timing of hospital admission at first childbirth: A prospective cohort study. PLoS ONE. 2023;18:e0281707. https:\/\/doi.org\/10.1371\/journal.pone.0281707.","journal-title":"PLoS ONE"},{"key":"2380_CR34","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/AOG.0000000000003649","volume":"135","author":"M Williams","year":"2020","unstructured":"Williams M, Zantow E, Turrentine M. Cost effectiveness of latest recommendations for group B streptococci screening in the United States. Obstet Gynecol. 2020;135:789\u201398.","journal-title":"Obstet Gynecol"},{"key":"2380_CR35","unstructured":"WHO Group B Streptococcus (GBS). https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/diseases\/group-b-streptococcus-(gbs). Accessed 11 Jul 2024"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02380-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-024-02380-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02380-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T19:50:03Z","timestamp":1739476203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-024-02380-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,8]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2380"],"URL":"https:\/\/doi.org\/10.1007\/s15010-024-02380-0","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,8]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Financial interests: Margarit I, Maione D and Rinaudo D are employees of the GSK group of companies and hold shares in the GSK group of companies. Margarit I, Maione D and Rinaudo D are listed as inventor on patents owned by the GSK group of companies. Uffe B. Skov S\u00f8rensen and Mogens Kilian received personal consultancy fees from Suzhou VACMICRO Biotech Co., Ltd. Non-financial interests: Markus Hufnagel has been invited by Novartis to an advisory board meeting on juvenile idiopathic arthritis. Pierrette Melin has provided one scientific consultation for GSK vaccines. All other authors have no financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by local ethics committees of each participating institution, and informed consent for study participation has been obtained from the legal caregivers. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}